Autoimmune Hemolytic Anemia in Treatment-Naïve Chronic Hepatitis C Infection

2010 ◽  
Vol 105 ◽  
pp. S261
Author(s):  
Robert Basseri ◽  
Benjamin Basseri
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Hemolytic Anemia ◽  
Autoimmune Hemolytic Anemia ◽  
Hepatitis C Infection ◽  
Treatment Naïve

scholarly journals Autoimmune hemolytic anemia in HCV/HIV coinfected patients during treatment with pegylated alpha-2a interferon plus ribavirin

2007 ◽  
Vol 40 (6) ◽  
pp. 678-680 ◽  
Author(s):  
Fernando Crivelenti Vilar ◽  
Gleusa de Castro ◽  
Maria Janete Moya ◽  
Ana de Lourdes Candolo Martinelli ◽  
Gil Cunha De Santis ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Treatment Period ◽  
Chronic Hepatitis C ◽  
Hemolytic Anemia ◽  
Autoimmune Hemolytic Anemia

Two cases of autoimmune hemolytic anemia that occurred during the treatment of chronic hepatitis C with pegylated alpha-2a interferon and ribavirin, in HIV coinfected patients, are presented and described. The late occurrence (after six months of therapy) of this severe hemolytic anemia leads to the recommendation that hemoglobin levels should be monitored throughout the treatment period, even among patients who presented stable hemoglobin levels in the preceding months.

scholarly journals Effectiveness of 8-Week Glecaprevir/Pibrentasvir for Treatment-Naïve, Compensated Cirrhotic Patients with Chronic Hepatitis C Infection

2020 ◽  
Vol 37 (5) ◽  
pp. 2267-2274 ◽  
Author(s):  
Steven L. Flamm ◽  
Jens Kort ◽  
Steven E. Marx ◽  
John Strezewski ◽  
Douglas E. Dylla ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Hepatitis C Infection ◽  
Treatment Naïve ◽  
Cirrhotic Patients
Sign in / Sign up

Export Citation Format

Share Document